The national surveillance protocol for invasive meningococcal disease in England
The national surveillance protocol for invasive meningococcal disease (IMD) in England has been extended in recognition of:
- changes to the meningococcal group C conjugate (MCC) vaccination programme, including the removal of the infant MCC dose at 4 months and the introduction of an adolescent MCC dose in June 2013
- the emergency introduction of a quadrivalent conjugate vaccine against meningococcal groups A, C, W, and Y (MenACWY) for 14 to 18 year olds in August 2015 in response to a national outbreak of a hypervirulent MenW
- the introduction of a MenB vaccine, Bexsero®, into the national infant immunisation schedule in September
The Meningococcal disease enhanced surveillance plan flowchart has been compiled to summarise and clarify the actions required by Public Health England health protection teams following the report of a suspected case of invasive meningococcal disease.
Record suspected or confirmed cases of invasive meningococcal disease using the enhanced surveillance forms for healthcare professionals.